Phase IV-An Open-Label Prospective Study of Memantine in Institutionalized Patients With Severe Alzheimer's Disease and Significant Behavioural and Psychological Symptoms of Dementia.

Trial Profile

Phase IV-An Open-Label Prospective Study of Memantine in Institutionalized Patients With Severe Alzheimer's Disease and Significant Behavioural and Psychological Symptoms of Dementia.

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 May 2012

At a glance

  • Drugs Memantine (Primary)
  • Indications Aggression; Agitation
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Feb 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 19 Dec 2009 Status changed from not yet recruiting to recruiting.
    • 05 Dec 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top